Françoise Gellibert
AVL (France)(FR)Servier (France)(FR)Institut des Hautes Études Scientifiques(FR)
Publications by Year
Research Areas
TGF-β signaling in diseases, Protein Degradation and Inhibitors, Computational Drug Discovery Methods, Multiple Myeloma Research and Treatments, Machine Learning in Materials Science
Most-Cited Works
- → Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains(2011)334 cited
- → Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors(2004)219 cited
- → Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis(2007)214 cited
- → Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)(2012)207 cited
- → Inhibition of TGF‐β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis(2005)164 cited
- → From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151(2012)118 cited